Leqembi (Lecanemab), a disease-modifying monoclonal antibody therapy, slows cognitive decline in early-stage Alzheimer’s disease by roughly 27% to 33%. Clinical Efficacy and the Mechanism of Action Leqembi is designed to … Read More
Recent clinical discussions highlight ashwagandha root extracts and their active biochemical components, withanolides, as measurable botanical interventions for chronic stress and sleep disturbances. Operating primarily through the hypothalamic-pituitary-adrenal (HPA) axis, … Read More
Recent gastroenterological research reveals that gut microbiome composition accounts for up to 97% of variance in systemic inflammatory markers. Published in clinical journals this season, these findings redefine how physicians … Read More
Following a high-profile political confrontation with German Chancellor Friedrich Merz, pediatrician Dr. Bea Merscher has publicly rejected the label “Wut-Ärztin” (angry doctor) in an interview with T-Online, focusing national attention … Read More
